BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25761906)

  • 1. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.
    Kang H; Kim KH; Lim J; Kim YS; Heo J; Choi J; Jeong J; Kim Y; Kim SW; Oh YM; Choo MS; Son J; Kim SJ; Yoo HJ; Oh W; Choi SJ; Lee SW; Shin DM
    Stem Cells Dev; 2015 Jul; 24(14):1658-71. PubMed ID: 25761906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with ceramide-1 phosphate promotes the therapeutic effect of mesenchymal stem/stromal cells on pulmonary artery hypertension.
    Lim J; Kim Y; Heo J; Kim KH; Lee S; Lee SW; Kim K; Kim IG; Shin DM
    Biochem Biophys Res Commun; 2016 Apr; 473(1):35-41. PubMed ID: 26993164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells.
    Lim J; Lee S; Ju H; Kim Y; Heo J; Lee HY; Choi KC; Son J; Oh YM; Kim IG; Shin DM
    Int J Mol Med; 2017 Sep; 40(3):739-747. PubMed ID: 28677769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis.
    Chen R; Cai X; Liu J; Bai B; Li X
    Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.
    Karapetyan AV; Klyachkin YM; Selim S; Sunkara M; Ziada KM; Cohen DA; Zuba-Surma EK; Ratajczak J; Smyth SS; Ratajczak MZ; Morris AJ; Abdel-Latif A
    Stem Cells Dev; 2013 Jun; 22(11):1645-56. PubMed ID: 23282236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated zinc and sphingosine-1-phosphate signaling in pulmonary hypertension: Potential effects by targeting of bone morphogenetic protein receptor type 2 in pulmonary microvessels.
    Tran HB; Maiolo S; Harper R; Zalewski PD; Reynolds PN; Hodge S
    Cell Biol Int; 2021 Nov; 45(11):2368-2379. PubMed ID: 34347342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
    Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
    J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells.
    Meriane M; Duhamel S; Lejeune L; Galipeau J; Annabi B
    Stem Cells; 2006 Nov; 24(11):2557-65. PubMed ID: 16931773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
    Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.
    Guo Y; Su L; Li Y; Guo N; Xie L; Zhang D; Zhang X; Li H; Zhang G; Wang Y; Liu C
    Heart Vessels; 2014 Jul; 29(4):520-31. PubMed ID: 23933910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells.
    Gonzalez E; Kou R; Michel T
    J Biol Chem; 2006 Feb; 281(6):3210-6. PubMed ID: 16339142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-Phosphate Induces the Migration and Angiogenesis of Epcs Through the Akt Signaling Pathway via Sphingosine-1-Phosphate Receptor 3/Platelet-Derived Growth Factor Receptor-β.
    Wang H; Cai KY; Li W; Huang H
    Cell Mol Biol Lett; 2015 Dec; 20(4):597-611. PubMed ID: 26208383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
    Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
    Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions.
    Zhao Z; Chen Z; Zhao X; Pan F; Cai M; Wang T; Zhang H; Lu JR; Lei M
    J Biomed Sci; 2011 Jun; 18(1):37. PubMed ID: 21645412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.
    Chen J; Tang H; Sysol JR; Moreno-Vinasco L; Shioura KM; Chen T; Gorshkova I; Wang L; Huang LS; Usatyuk PV; Sammani S; Zhou G; Raj JU; Garcia JG; Berdyshev E; Yuan JX; Natarajan V; Machado RF
    Am J Respir Crit Care Med; 2014 Nov; 190(9):1032-43. PubMed ID: 25180446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
    Oh S; Jang AY; Chae S; Choi S; Moon J; Kim M; Spiekerkoetter E; Zamanian RT; Yang PC; Hwang D; Byun K; Chung WJ
    Sci Rep; 2021 Jan; 11(1):2012. PubMed ID: 33479312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of sphingosine-1-phosphate signaling to control human chorionic mesenchymal stem cell physiology.
    Innamorati G; Fontana E; Steccanella F; Gandhi K; Bassi G; Zandonà V; Giacomello L
    Cell Death Dis; 2017 Jul; 8(7):e2930. PubMed ID: 28703804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.